Helicobacter pylori Interaction with Human Gastric and
Source Bartfeld et al. · Max Planck Institute for Infection Biology, Berlin, Germany · 10.1053/j.gastro.2014.09.042
Abstract
Established the first human organoid model of H. pylori infection demonstrating active CagA oncoprotein injection via the Type IV secretion system into gastric epithelial cells. Infected organoids showed characteristic cell elongation and NF-κB inflammatory signaling, recapitulating key pathogenic events.
Protocol overview
55 steps across 7 phases
- 1 Obtain human gastric corpus tissue
- 2 Extract glands using EDTA chelation
- 3 Enzymatic digestion of cancer tissue (if applicable)
- 4 Wash digested cells
- 1 Seed glands or cells in Matrigel
- 2 Prepare complete culture medium (ENRWFG_Ti)
- 3 Add RHOK inhibitor post-seeding
- 4 Culture organoids at 37°C in 5% CO₂
- 5 Monitor organoid formation
- 6 Perform first medium change
- 7 Continue medium changes every 3–4 days
- 1 Prepare organoids for passage (Day 7–10 of culture)
- 2 Remove culture medium
- 3 Wash with cold phosphate-buffered saline (PBS)
- 4 Mechanically and enzymatically dissociate organoids
- 5 Collect dissociated organoid suspension
- 6 Centrifuge and wash
- 7 Count viable cells
- 8 Seed dissociated cells at 1:5 split ratio
- 9 Overlay with fresh ENRWFG_Ti medium
- 10 Repeat passages every 1–2 weeks
- 1 Generate gland-type organoids (Wnt-dependent)
- 2 Induce pit-type differentiation by Wnt withdrawal
- 3 Verify differentiation phenotype
- 4 Generate complete-type organoids
- 1 Prepare organoids in antibiotic-free medium
- 2 Prepare H. pylori bacterial culture
- 3 Calculate multiplicity of infection (MOI) for microinjection
- 4 Perform microinjection of H. pylori into organoids
- 5 Verify successful injection
- 6 Assess bacterial viability post-injection
- 7 Culture infected organoids
- 8 Harvest infected organoids for downstream analysis
- 9 Prepare controls for infection studies
- 10 Test alternative inflammatory stimuli (optional)
- 1 Dissociate organoids into single cells
- 2 Count cells and assess viability
- 3 Prepare cells for fluorescence-activated cell sorting (FACS)
- 4 Gate on singlets using forward scatter (FSC)
- 5 Sort single cells into culture wells
- 6 Verify sort quality by microscopy
- 7 Seed sorted single cells in Matrigel with RHOKi
- 8 Monitor single-cell organoid formation
- 9 Perform first passage of single-cell-derived organoids
- 10 Characterize clonal organoids
- 1 Isolate and prepare cancer tissue
- 2 Enzymatic digestion of cancer tissue
- 3 Wash dissociated cancer cells
- 4 Seed cancer cells in Matrigel
- 5 Overlay with complete culture medium (ENRWFG_A)
- 6 Culture and maintain tumor organoids
- 7 Perform karyotyping on tumor organoids
- 8 Characterize tumor organoid morphology and marker expression
- 9 Functional characterization: p53 pathway assessment (optional)
- 10 Long-term expansion and drug testing
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Bartfeld et al.. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol